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Abstract: 
The neurodevelopmental vulnerability for schizophrenia appears to be expressed across a 
dynamic continuum of adjustment referred to as schizotypy. This model suggests that 
nonpsychotic schizotypic individuals should exhibit mild and transient forms of symptoms seen 
in full-blown schizophrenia. Given that depression and anxiety are reported to be comorbid with 
schizophrenia, the present study examined the relationship of psychometrically defined 
schizotypy with symptoms of depression and anxiety in a college student sample (n = 1258). A 
series of confirmatory factor analyses indicated that a three-factor solution of positive 
schizotypy, negative schizotypy, and negative affect provided the best solution for self-report 
measures of schizotypy, anxiety, and depression. As hypothesized, the model indicated that 
symptoms of depression and anxiety are more strongly associated with the positive-symptom 
dimension of schizotypy than with the negative-symptom dimension. This is consistent with 
studies of schizophrenic patients and longitudinal findings that positive-symptom schizotypes are 
at risk for both mood and non-mood psychotic disorders, while negative-symptom schizotypes 
appear more specifically at risk for schizophrenia-spectrum disorders. 
chizotypy | schizophrenia | anxiety | depression | psychology Keywords: s
 
Article: 
1. Introduction 
1.1. Schizophrenia and schizotypy 
The present study examined the relationship of psychometrically defined schizotypy with 
symptoms of depression and anxiety in a college student sample. Following Meehl (e.g., 1990), 
schizotypy is defined as the personality organization that conveys the risk for schizophrenia. 
Schizotypy is presumed to result from processes of neural dysmaturation, consistent with the 
theories of Andreasen (1999), Keshavan (1997),Murray and Lewis (1987), and Weinberger 
(1987). It is assumed that the majority of schizotypes will never decompensate, although they 
may demonstrate mild and/or transient signs of schizophrenia including neurocognitive and 
biobehavioral deficits, clinical and subclinical symptoms, and social impairment. This 
formulation suggests that schizotypy is expressed on a dynamic continuum ranging from relative 
psychological health to subclinical deviance to schizophrenia-spectrum personality disorders to 
full-blown schizophrenia, with severity contingent on the interaction of biopsychosocial factors 
(Gooding and Iacono, 1995). Since compensated schizotypes are hypothesized to share a 
common neurodevelopmental pathway with schizophrenia patients, it is expected that they will 
exhibit subclinical and clinical forms of the cognitive, emotional, and behavioral features of 
schizophrenia. 
Schizotypy has been described as a multidimensional construct consisting of two or more factors. 
Consistent with multidimensional models of schizophrenia, candidate factors include positive 
schizotypy, negative schizotypy, cognitive disorganization, paranoia, and nonconformity 
(e.g., [Claridge et al., 1996],[Mason et al., 1997], [Raine et al., 1994], [Stefanis et al., 
2002] and [Vollema and van den Bosch, 1995]). Positive and negative symptom schizotypy are 
the most consistently replicated factors. While there is not a universally agreed upon latent 
structure of schizotypy, the proposed factors appear consistent with those hypothesized to 
comprise schizophrenia, including positive, negative, and disorganized dimensions (e.g.,[Arndt 
et al., 1991], [Bilder et al., 1985], [Liddle, 1987] and [Peralta et al., 1992]). Findings of parallel 
facture structures add empirical support to the hypothesis that the neurodevelopmental 
vulnerability to schizophrenia is expressed across the continuum of schizotypy. 
1.2. Relationship of schizophrenia with mood and anxiety symptoms 
Mood and anxiety symptoms are frequently present in patients with schizophrenia and related 
conditions. While these symptoms are often considered associated features and do not warrant a 
separate diagnosis, rates of comorbid depression and anxiety disorders are elevated in patients 
with schizophrenia according to the Diagnostic and Statistical Manual-4th Edition-Text Revision 
(DSM-IV-TR; American Psychiatric Association, 2000). Investigations of mood symptoms in 
schizophrenic patients have found rates of depressive symptoms in 30–75% of psychiatric 
inpatients ( [Bottlender et al., 2000], [Elk et al., 1986],[Koreen et al., 1993] and [Möller and von 
Serssen, 1981]) Additionally, Martin et al. (1985) found that nearly 60% of patients with 
schizophrenia had experienced a depressive syndrome at some time during the course of their 
illness. This overlap has been acknowledged by the inclusion of the provisional diagnosis of 
postpsychotic depressive disorder of schizophrenia in DSM-IV-TR. 
Many of the symptom features of schizophrenia-spectrum disorders overlap with symptom 
features of depression (e.g., social withdrawal, anhedonia) and anxiety (e.g., worry, 
concentration difficulties). Notably, depression and anxiety appear to share a number of 
phenotypic similarities with the negative symptom dimension of schizophrenia. However, 
anxiety and depression appear to be more strongly associated with the positive factor of 
schizophrenia than the negative factor ( [Emsley et al., 1999] and [Lysaker et al., 1995]), 
suggesting that negative symptom schizophrenia reflects a relative deficit in affect that is 
inconsistent with the experience of anxiety and depression. For example, Drake et al. 
(2004) found that paranoia (a positive symptom) predicted elevated depression in schizophrenia 
and spectrum disorder patients. Furthermore, positive symptoms of schizophrenia and mood 
symptoms tend to indicate a better prognosis in schizophrenia, while negative symptoms are 
associated with a poorer prognosis (e.g.,Oosthuizen et al., 2002). 
The notion that the vulnerability to schizophrenia is expressed across the continuum of 
schizotypy suggests that schizotypic individuals who do not decompensate may nonetheless 
experience clinical and subclinical forms of the psychopathology seen in schizophrenic patients, 
including elevated rates of mood and anxiety symptoms and disorders. Additionally, DSM-IV-
TR indicates that over half of all patients with schizotypal personality disorder experience at 
least one episode of major depression. Baron and Gruen (1991) reported that relatives of patients 
with schizophrenia experienced elevated rates of major depressive disorder, regardless of the 
presence of schizophrenia-spectrum psychopathology, and Cardno et al. (1999) suggested that 
there is a common liability between mood and non-mood psychotic disorders. 
A number of studies examining anxiety and mood symptoms or disorders in psychometrically 
identified schizotypic individuals have found that, consistent with reports in schizophrenia 
patients, anxiety and depression appear to be more strongly associated with positive schizotypy 
than with negative schizotypy.Lenzenweger and Loranger (1989) administered the Perceptual 
Aberration Scale (Chapman et al., 1978), a psychometric measure of positive schizotypy, to 
nonpsychotic psychiatric patients, and evaluated them using structured interviews for Axis I and 
Axis II disorders. Subjects were also rated on anxiety, depression, social competence, and 
severity of illness. They found that scores on the Perceptual Aberration Scale were significantly 
correlated with anxiety and depression. [Chapman et al., 1994a] and [Chapman et al., 
1994b]reported significantly higher rates of major depressive disorder in schizotypic participants 
identified by elevated scores on the Perceptual Aberration Scale and Magical Ideation Scale 
(Eckblad and Chapman, 1983), both measures of positive schizotypy, compared to control 
participants at baseline and 10-year follow-up assessments. Day and Peters (1999) reported that 
anxiety and depression were correlated with positive symptom factors on the Oxford-Liverpool 
Inventory of Feelings and Experiences (O-LIFE; Mason et al., 1995) including Unusual 
Experiences and Cognitive Distortions, and with the Schizotypal Personality Scale 
(STA; Claridge and Broks, 1984), which assesses positive symptoms. Nunn et al. (2001) found 
that scores on the Impulsivity Nonconformity factor of the O-LIFE were positively correlated 
with anxiety and depression in nonpsychotic undergraduates. In contrast, questionnaires that 
assess negative schizotypy, such as the Physical Anhedonia Scale (Chapman et al., 1976) and the 
Revised Social Anhedonia Scale (Eckblad et al., 1982) were not associated cross-sectionally or 
at 10-year reassessments with mood disorders ( [Chapman et al., 1994a], [Chapman et al., 
1994b] and [Kwapil, 1998]). 
1.3. Goals and hypotheses of the present study 
The goals of the current study were to examine the dimensional structure of schizotypy in a large 
sample of nonpsychotic young adults and to examine the relationship of symptoms of depression 
and anxiety with these dimensions of schizotypy. While college graduates exhibit a slightly 
lower lifetime prevalence of schizophrenia than the general population (Robins et al., 1984), they 
appear to provide an appropriate sample for a preliminary examination of the relationship of 
schizotypy with depression and anxiety, as longitudinal studies have reported that 
psychometrically identified schizotypic college students are at heightened risk for developing 
mood and non-mood psychotic disorders and schizophrenia-spectrum illnesses (e.g., [Chapman 
et al., 1994a], [Chapman et al., 1994b] and [Kwapil, 1998]). In the present study, it is 
hypothesized that, a) psychometrically assessed schizotypy in nonpsychotic adults will yield a 
factor structure similar to that seen in schizophrenia, with two prominent factors emerging: a 
positive symptom factor and a negative symptom factor, b) consistent with findings from the 
schizophrenia literature, schizotypy will be positively associated with symptoms of depression 
and anxiety, and c) depression and anxiety symptoms will have a stronger association with the 
positive symptom factor than with the negative symptom factor of schizotypy. 
2. Method 
2.1. Participants 
The final sample included 260 male and 998 female college undergraduates enrolled in 
introductory psychology courses at the University of North Carolina at Greensboro. The mean 
age of the sample was 19.4 (SD = 3.7). The sample was 75.5% Caucasian and 24.5% African 
American. Males and females did not differ on age or ethnic composition. 
2.2. Materials 
Participants were administered the Perceptual Aberration, Magical Ideation, Revised Social 
Anhedonia, and Physical Anhedonia Scales, the Beck Anxiety Inventory (BAI; Beck and Steer, 
1993), the Beck Depression Inventory-II (BDI; Beck et al., 1996), and a 13-item infrequency 
scale (Chapman and Chapman, 1983) that was designed to screen out subjects who responded in 
a random or “fake-bad” manner. 
2.2.1. Schizotypy scales 
The schizotypy scales consist of four true–false self-report questionnaires that assess 
schizophrenic-like beliefs and experiences. The Perceptual Aberration Scale contains 35 items 
that assess schizophrenic-like perceptual experiences and bodily distortions. The Magical 
Ideation Scale contains 30 items that tap a belief in implausible or invalid causality. The Revised 
Social Anhedonia Scale is comprised of 40 items that assess asociality and indifference 
regarding interpersonal relationships. The Physical Anhedonia Scale includes 61 items that tap 
deficits in sensory and aesthetic pleasure. The Perceptual Aberration and Magical Ideation Scales 
tap positive schizotypy, the Physical Anhedonia Scale assesses negative schizotypy, and the 
Revised Social Anhedonia Scale appears to tap aspects of both dimensions of schizotypy. 
2.2.2. Beck depression inventory 
The BDI is a 21 item questionnaire that assesses state depression during the past week. Items are 
rated from zero, indicating that the symptom was not endorsed, to three, indicating that the 
symptom is prominently experienced. 
2.2.3. Beck anxiety inventory 
The BAI is a 21-item questionnaire that assesses state anxiety during the past week. As with the 
BDI, each item is rated from zero to three with higher scores indicating more severe anxiety 
symptoms. 
2.3. Procedure 
Participants completed the above measures, as well as other measures not included in the present 
study, as part of the Department of Psychology mass screening. The assessment lasted between 
1-1/2 and 2 h. Participants who endorsed three or more items on the infrequency scale (5.1%) or 
who failed to complete all of the items were excluded from the analyses (7.2%). Students 
received course credit for their participation. 
3. Results 
3.1. Descriptive statistics 
Table 1 contains descriptive statistics for each of the scales separately by gender. Scores on the 
schizotypy scales were converted to standard scores based on normative data from 644 male and 
1835 female college students enrolled at the University of North Carolina at Greensboro (Kwapil 
et al., 2002). The alpha level was set at .001 due to the large sample size in order to minimize 
Type I errors and to reduce the likelihood of reporting statistically significant but inconsequential 
findings. For the sake of brevity, analyses are presented for the male and female participants 
combined, as the results were substantively unchanged when computed separately by sex. 
 
Table 1. Descriptive data for the schizotypy, depression, and anxiety measures 
 Mean SD Alpha Skew Kurtosis 
Males (n = 260) 
Psychosis-proneness scales      
 Perceptual aberration 5.7 5.0 .85 1.7 4.5 
 Magical ideation 9.1 5.6 .84 0.6 − 0.2 
 Social anhedonia 10.5 6.9 .88 1.3 2.0 
 Physical anhedonia 16.1 8.7 .88 0.6 − 0.2 
Beck Depression Inventory 6.2 5.8 .92 1.6 3.3 
Beck Anxiety Inventory 10.9 9.9 .91 1.4 2.0 
 Females (n = 998) 
 Mean SD Alpha Skew Kurtosis 
Psychosis-proneness scales      
 Perceptual aberration 5.4 5.2 .87 1.9 5.1 
 Magical ideation 9.0 5.5 .83 0.7 0.1 
 Social anhedonia 8.0 5.9 .86 1.3 2.2 
 Physical anhedonia 12.2 6.7 .83 0.8 0.6 
Beck Depression Inventory 7.3 6.4 .90 1.6 3.5 
Beck Anxiety Inventory 12.5 10.3 .91 1.1 1.1 
Alpha=coefficient alpha internal consistency reliability. 
 
3.2. Correlational analyses 
Table 2 contains the zero-order correlations between scores on the schizotypy scales, the BDI, 
and the BAI. Consistent with previous findings (Chapman et al., 1982), the Perceptual 
Aberration and Magical Ideation Scales were significantly correlated, as were the Social 
Anhedonia and Physical Anhedonia scales. The Physical Anhedonia Scale was not correlated 
with Perceptual Aberration or Magical Ideation scores. The Social Anhedonia Scale was 
significantly, though modestly, correlated with the Perceptual Aberration and Magical Ideation 
Scales-consistent with the finding that Social Anhedonia taps aspects of both positive and 
negative schizotypy. The BDI and the BAI were significantly correlated, and were correlated 
with all four schizotypy scales. However the correlation of the depression and anxiety measures 
with the Physical Anhedonia Scale was rather modest compared to the correlations with the other 
schizotypy scales (.17 and .12, respectively). We also examined whether curvilinear components 
accounted for significant variance over-and-above the linear relationships between negative 
affect and schizotypy. The quadratic components were significant, albeit modest, in the 
relationships of the BAI with the Perceptual Aberration and Social Anhedonia Scales indicating 
a flattening of this relationship at high levels of these schizotypy scales. None of the quadratic 
components in the other relationships accounted for significant variance over that of the linear 
component. 
 
Table 2. Zero-order correlations among schizotypy, depression, and anxiety measures 
(n = 1254) 
 PerAb MagId PhyAnh SocAnh BDI BAI 
PerAb 1.00      
MagId .67⁎ 1.00     
PhyAnh − .01 − .12⁎ 1.00    
SocAnh .36⁎ .25⁎ .38⁎ 1.00   
BDI .36⁎ .27⁎ .17⁎ .36⁎ 1.00  
 PerAb MagId PhyAnh SocAnh BDI BAI 
BAI .34⁎ .36⁎ .12⁎ .24⁎ .48⁎ 1.00 
PerAb = Perceptual Aberration Scale; MagId = Magical Ideation Scale; PhyAnh = 
Physical Anhedonia Scale; SocAnh = Revised Social Anhedonia Scale; BDI = Beck 
Depression Inventory; BAI = Beck Anxiety Inventory. 
p < .001. 
 
3.3. Confirmatory factor analyses 
Confirmatory factor analyses were conducted to examine the factor structure of schizotypy and 
its relationship with ratings of anxiety and depression. The sample size (n = 1258) and the 
number of participants per observable variable was sufficient for conducting confirmatory factor 
analyses following recommendations of Anderson and Gerbing (1984) and Bentler and Chou 
(1987). Following the recommendations of Little et al. (2002), the items for each of the 
schizotypy scales were divided into three “parcels” in order to produce more robust estimates. 
The residuals from each parcel within a schizotypy scale were allowed to correlate given the 
common source. Goodness of fit was assessed using multiple indicators listed in Table 3, 
including the Goodness of Fit Index (GFI), Adjusted GFI, Normed Fit Index (NFI), Comparative 
Fit Index (CFI), Root Mean Square Error of Approximation (RMSEA), and the chi-square 
statistic. Adequate fit of the model to the data is generally indicated by fit indices greater than 
.95, RMSEA less than .05, and nonsignificant chi-square statistics ( [Bentler and Bonnet, 
1980] and [Browne and Cudeck, 1993])—although with a sample size this large, it is unlikely to 
report a nonsignificant chi-square value. We tested four models based upon a priori hypotheses 
to examine factor structure. The first (default) model did not differentiate an underlying factor 
structure for schizotypy, anxiety, or depression—letting all the variables load on a generic 
psychopathology factor. As seen in Table 3, the fit for this model was poor. The second model 
included a nondifferentiated schizotypy factor with loadings from all four schizotypy scales and 
a “general negative affect” factor with loadings from the BDI and BAI. This model also failed to 
provide adequate fit for the data. The third model included a positive schizotypy factor with 
loadings from the Perceptual Aberration and Magical Ideations Scales, a negative schizotypy 
factor with loadings from the Revised Social Anhedonia and Physical Anhedonia Scales, and the 
general negative affect factor. This model provided improved fit for the data, but still failed to 
provide adequate fit. The final model was the same as the previous, except that the Revised 
Social Anhedonia Scale was allowed to load on both of the schizotypy factors. This three-factor 
model provided an excellent fit for the data. Given that the models were nested, the change in 
chi-square and degrees of freedom were evaluated with each successive model. In every case the 
subsequent model provided significantly improved fit over the preceding model. Note that in 
both of the three-factor models, the negative affect factor was more strongly associated with 
positive schizotypy than negative schizotypy. Fig. 1 contains the standardized coefficients for the 
final three-factor model. 
 
Table 3. Confirmatory factor analyses of schizotypy, anxiety, and depression 
Model GFI AGFI NFI CFI RMSEA RMSEA 
CI 
χ2 (df) p-
value 
Δχ2 (Δdf) p-
value 
Unidimensional .87 .80 .89 .89 .108 .102–
.114 
1031.2 
(66) 
< .001   
Two-factora .88 .81 .90 .91 .100 .094–
.106 
885.9 
(65) 
< .001 145.3 (1) < .001 
Three-factorb .97 .96 .97 .98 .047 .041–
.054 
240.1 
(63) 
< .001 645.8 (2) < .001 
Three-factorc .99 .97 .99 .99 .031 .024–
.038 
133.2 
(60) 
< .001 107.7 (3) < .001 
 Model GFI AGFI NFI CFI RMSEA RMSEA 
CI 
χ2 (df) p-
value 
Factor invariance across sex and 
ethnicity 
        
 Unconstrained .96 .94 .96 .99 .018 .013–
.022 
336.2 
(240) 
 <.001 
 Regression weights constrained .96 .94 .96 .99 .018 .013–
.022 
390.4 
(282) 
< .001 
 Structural covariances constrained .95 .93 .95 .98 .021 .017–
.025 
467.7 
(300) 
< .001 
 
FI = Goodness of Fit Index, AGFI = Adjusted Goodness of Fit Index, NFI = Normed Fit Index, 
CFI = Comparative Fit Index, RMSEA = Root Mean Square Error of Approximation, RMSEA 
CI = 90% Confidence Interval for RMSEA. 
a  General schizotypy factor (with loadings from the Perceptual Aberration, Magical Ideation, 
Physical Anhedonia, and Revised Social Anhedonia Scales); Negative affect factor (with 
loadings from the Beck Depression and Beck Anxiety Inventories). 
 
b Positive schizotypy factor (with loadings from the Perceptual Aberration and Magical Ideation 
Scales); Negative schizotypy factor (with loadings from the Revised Social Anhedonia and 
Physical Anhedonia Scales); Negative affect factor (with loadings from the Beck Depression and 
Beck Anxiety Inventories). 
 
c Positive schizotypy factor (with loadings from the Perceptual Aberration, Magical Ideation and 
Revised Social Anhedonia Scales); Negative schizotypy factor (with loadings from the Revised 
Social Anhedonia and Physical Anhedonia Scales); Negative affect factor (with loadings from 
the Beck Depression and Beck Anxiety Inventories). 
 
FIGURE 1 IS OMITTED FROM THIS FORMATTED DOCUMENT 
Fig. 1. Three factor solution with standardized coefficients. 
 
3.4. Factor invariance across sex and ethnicity 
In order to test the invariance of the factor structure across sex and ethnicity, a multi-group, 
multi-model comparison was conducted using the final three-factor structure reported above. In 
the first model, the subscales were allowed to load freely on the schizotypy factors for each of 
the four sex-by-ethnicity groups (e.g., African American females). In the second model, the 
regression weights (but not the structural covariances) were constrained to be identical across the 
four sex/ethnicity groups. The final model was the most restrictive in that it constrained the 
factor variances and covariance, in addition to the regression weights across the four groups. As 
seen in Table 3, the two constrained models fit the data equally as well as the model in which the 
factor loadings were allowed to vary freely, supporting the comparability of the factor structure 
across sex and ethnicity. 
3.5. Bootstrap procedures 
As noted in Table 1, the distributions of scores departed from normality. Following the 
recommendation ofWilcox and Muska (2001), the correlations reported in Table 2 and the final 
confirmatory factor analysis model reported in Table 3 were computed using bootstrap 
procedures. In each case, the analysis was computed using 1000 bootstrap samples, and the 
difference (bias) between the original coefficients and the bootstrapped coefficients was 
determined. In every analysis, all 1000 bootstrap samples were usable. The bias values for the 
correlations presented in Table 2 ranged from − 0.002 to 0.001, supporting the original estimates. 
Likewise, the bias was minimal for the standardized regression weights (bias range: − 0.001 to 
0.0005) and the correlation coefficients (− 0.003 to − 0.001) in the confirmatory factor analysis. 
The results of the bootstrap analyses support the findings of the original analyses. 
4. Discussion 
Clinical observation, as well as epidemiological and laboratory studies, have established that 
anxiety and depressive symptoms and disorders are frequently comorbid with schizophrenia and 
spectrum disorders. Furthermore, such symptoms appear to be more strongly associated with 
positive than negative dimensions of schizophrenia. Consistent with these relationships, the 
present study found that self-reported depressive and anxious symptoms are positively associated 
with psychometric ratings of schizotypy in a large, nonclinical sample, and that they are more 
highly associated with positive symptom than negative symptom schizotypy. The present 
findings, along with clinical observation, are consistent with the notion that both positive 
schizotypy and anxiety/depression involve dysregulation of affect—especially regarding the 
experience of negative affect. Negative schizotypy, on the other hand, involves a diminution of 
affective tone and response. While the present study is descriptive and correlational, it provides 
impetus for laboratory study of the nature of these relationships. Note that consistent with 
numerous empirical findings (e.g.,[Brown et al., 2001] and [Clark and Watson, 1991]), we 
hypothesized and found that anxiety and depression would load on a common factor. However, 
the exact relationship of depression and anxiety remains an intriguing controversy separate from 
the goals of the present investigation (e.g., Maser and Cloninger, 1990). 
The confirmatory factor analyses indicated that the best fitting model consisted of two separate 
factors of schizotypy (positive and negative), and a third factor of negative affect (with loadings 
of symptoms of anxiety and depression). The present findings support the view of schizotypy as 
a multidimensional construct (e.g., Vollema and van den Bosch, 1995) that coexists with an 
affective/anxious dimension in the realm of normal individual differences. These findings are 
consistent with the idea that schizophrenia reflects the extreme manifestation of a continuum of 
schizotypy. This model is based upon the idea that the neurodevelopmental vulnerability to 
schizophrenia is expressed across the continuum of schizotypy. It is expected that the same 
spectrum of cognitive, emotional, and behavioral dysfunctions should be expressed across 
schizotypy, with increasing severity towards the schizophrenic end of the continuum. In other 
words, core clinical and subclinical features of schizophrenia, such as cognitive/perceptual 
impairments and negative symptoms will be found across the dimension of schizotypy. Likewise, 
comorbid and associated features of schizophrenia, such as anxiety and depression, are also 
expected to be found at higher rates among schizotypic individuals. Consistent with previous 
cross-sectional and longitudinal studies (e.g.,[Chapman et al., 1994a], [Chapman et al., 
1994b] and [Lenzenweger and Loranger, 1989]), the present findings support the use of 
psychometric screening inventories for assessing schizotypy. 
The finding that the confirmatory factor analyses only identified positive and negative 
dimensions of schizotypy was not meant to imply that there are only two factors underlying the 
construct. Positive and negative symptom dimensions are the most widely reported factors of 
schizotypy and schizophrenia; however, our focus on these factors admittedly reflects the nature 
of the measures administered. There is ample evidence supporting a cognitive disorganization 
factor ( [Claridge et al., 1996], [Reynolds et al., 2000] and [Vollema and Hoijtink, 2000]) and a 
paranoid factor (Stefanis et al., 2004), although there is considerably less clarity regarding the 
number and nature of additional factors, such as a nonconformity factor ( [Chapman et al., 
1994a], [Chapman et al., 1994b], [Claridge et al., 1996] and [Mason et al., 1997]). 
Current models of schizotypy tend to be divided between views that schizotypy is taxonic in 
nature, based initially on work by Meehl (e.g., Meehl, 1990), and views of schizotypy as a 
normally distributed personality trait, popularized by Claridge (e.g., Claridge, 1997). The present 
study suggests that there are linear relationships between psychometric measures of schizotypy 
and measures of anxiety and depression. However, this does not necessarily imply that there is 
meaningful variance related to schizotypy across the range of scores. Ultimately, it is beyond the 
scope of this work to disentangle this complicated issue. 
The three-factor model in which the Revised Social Anhedonia Scale loaded exclusively on the 
negative schizotypy factor alongside the Physical Anhedonia Scale did not provide as good a fit 
to the data as the final model in which the Revised Social Anhedonia Scale was allowed to load 
on both the positive and negative schizotypy factors. These results seem counter-intuitive given 
the core and apparently specific nature of anhedonia to negative schizotypy. However, this 
finding is consistent with the modest positive correlation of the Revised Social Anhedonia Scale 
with measures of positive schizotypy (e.g., Pope and Kwapil, 2000) and with clinical 
assessments of participants identified by deviantly high scores on this scale.Kwapil 
(1998) reported that socially anhedonic college students exhibited elevated rates of 
schizophrenia-spectrum disorders and psychotic-like (positive) symptoms at a 10-year follow-up 
assessment. Similarly,Diaz et al. (2003) reported that Social Anhedonia participants exceeded 
control participants on ratings of both psychotic-like and negative symptoms. In both studies, the 
findings were independent of scores on the Perceptual Aberration and Magical Ideation Scales. 
These findings are especially striking considering that the items on the Revised Social 
Anhedonia Scale simply inquire about disinterest in social contact—none of the items assess 
unusual perceptual experiences or magical beliefs. 
The finding that the Revised Social Anhedonia Scale taps both positive and negative schizotypy 
dimensions can be considered both in conceptual terms (regarding the underlying nature of 
schizotypy) and in methodological terms (regarding what the scale assesses). Our present 
findings, consistent with an established theoretical and empirical literature, support a 
multidimensional view of schizotypy that contains (at least) positive and negative factors. Both 
of the three-factor models we proposed and tested support the presence of these dimensions. 
Therefore, the results are consistent with current multidimensional conceptualizations of 
schizotypy, but raise questions about why the Revised Social Anhedonia Scale taps both of these 
established dimensions. We hypothesize that the relationship of the Revised Social Anhedonia 
Scale with measures of positive schizotypy likely reflects: a) that consistent with the original 
conceptualizations of Paul Meehl (1962) social anhedonia is a core feature of schizotypy, and b) 
that despite the fact that the scale was designed to assess social disinterest, it likely also taps 
social anxiety and discomfort, which involve affective dysregulation and are likely to be 
associated with positive schizotypy. 
Conversely, the Physical Anhedonia Scale, which has a moderate positive correlation with the 
Revised Social Anhedonia Scale, tends to be uncorrelated or negatively correlated with scales 
that assess positive schizotypy (consistent with the findings in the present study). The differential 
pattern of relationships of Physical and Social Anhedonia with positive schizotypy is also 
consistent with findings from factor (e.g.,[Kendler and Hewitt, 1992] and [Venables and Bailes, 
1994]) and cluster (e.g., Williams, 1994) analyses. The most striking evidence comes from a 
factor analysis of Venables' Schizotypy Scale (Venables et al., 1990), which indicated that, 
contrary to the most common finding, Physical and Social Anhedonia loaded on two separate 
factors (Venables and Bailes, 1994). Such a difference is also in agreement with the finding that 
the Social but not Physical Anhedonia significantly enhanced the predictive power of the 
Magical Ideation Scale for identifying risk for development psychotic disorders in a 10-year 
longitudinal study ( [Chapman et al., 1994a] and [Chapman et al., 1994b]). 
There has been considerable controversy about the emotional experience of schizophrenic and 
schizotypic individuals. While flattened or diminished affect is characteristic of negative 
symptom schizophrenia, recent findings have suggested that the emotional life of schizophrenic 
patients might be much richer than they report or exhibit (e.g., [Kring and Neale, 
1996] and [Myin-Germeys et al., 2000]). The confirmatory factor analyses in the present study 
indicated that self-reported negative affect is more strongly associated with positive schizotypy 
than negative schizotypy. Nevertheless, the present findings indicated that both positive and 
negative schizotypy were significantly associated with self-reported negative affect. 
Depression and anxiety are associated with a more favorable prognosis in patients with 
schizophrenia, as is primarily positive-symptom schizophrenia. The obvious exception to this 
finding is that depression is associated with an increased risk of suicidality in schizophrenia. The 
general finding, however, is consistent with the fact that depression and anxiety symptoms are 
more closely associated with positive than negative factor schizotypy. However, the presence of 
depression and anxiety in premorbid or prodromal schizotypy appears to increase the risk of 
transition into psychosis (e.g. Yung et al., 2003). This suggests that, while positive symptoms 
and their correlates may be indicative of a better prognosis for patients with schizophrenia, the 
distress associated with affective disturbance and anxiety may hasten decompensation. Attempts 
to identify premorbid and prodromal individuals prior to decompensation in an effort to forestall 
the transition into full-blown psychosis have received increasing attention. The present findings 
together with recent studies suggest that early identification and prophylactic treatment strategies 
should include attention to symptoms of depression and anxiety, as these symptoms are 
associated with schizotypy and may be negative indicators of decompensation. 
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